NITI Aayog’s new roadmap says if Ayurveda wants to be taken seriously abroad, it can’t rely on ancient wisdom alone. It needs clinical trials, safety data, and global regulatory approval. The twist? Most global studies don’t fit Ayurveda’s ‘whole-body’ approach; they test one pill at a time. So India’s challenge isn’t just proving Ayurveda works; it’s inventing new ways to study it. Think real-world trials, not just labs. Think insurance reimbursements, not just spa packages. The big goal? Not just selling herbs overseas; but getting Ayurveda into hospitals and health systems. And that starts with proving, for specific conditions like back pain or gut issues, that it actually helps; and how. The roadmap sets a 2047 deadline. Smart. Because you can’t rush credibility. And if India gets this right, Ayurveda won’t just be a wellness trend; it could become real medicine, worldwide.